Banks

China Jushi, which makes fibreglass, is seeking a $150m debut borrowing through sole mandated lead arranger and bookrunner Standard Chartered.

Mapletree Logistics Trust is issuing a block of new shares to raise around S$250m ($183.6m) from investors.

Brazilian port terminal owner Prumo Participações e Investimentos should be able to tighten pricing by quite some way on Tuesday after announcing initial price thoughts that offered a generous pick-up of to similarly rated Brazilian credits.

China Huarong Financial Leasing Co and two local government financing vehicles (LGFVs) based in the coastal province of Jiangsu came to the offshore bond market to raise $300m each.

Streaming giant Netflix is in the market for $2bn with a 10.5-year bond issue split between euros and dollars. The unsecured senior notes come with a non-call life clause, offered to investors as a carrot.

Private equity-backed single-Bs are hitting the high yield market with a rapid-fire of refinancings. Evoca, Recordati and Schoeller Allibert priced successfully on Friday.

France’s Pernod Ricard is in the market on Monday for a €1.5bn trade, with the drinks company striking while the iron is hot to print debt after being upgraded by two agencies last week.

Carnival, the Anglo American cruise company, has launched a €600m 10 year trade, with the corporate bond pipeline filling fast.

CPPIB Capital has begun marketing its first 10 year dollar bond in two years as it looks to become the latest public sector borrower to visit this part of the curve, despite the underwhelming demand for World Bank’s trade last week.

Landesbank Baden-Württemberg (LBBW) met investors this week to discuss a debut sale of additional tier one (AT1) bonds. Changes in regulation are prompting issuers to seek new deals in the asset class to optimise their capital layers.

The European Stability Mechanism has chosen a five year tenor to kick off its funding for the fourth quarter. Meanwhile, a French public sector agency is out with its debut sustainable benchmark bond.

Denmark’s Bavarian Nordic will buy two commercial vaccines from GlaxoSmithKline for €796m, in a debt funded acquisition that will be refinanced next year in the equity market.